BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33553144)

  • 1. Progression Risk Assessment of Post-surgical Papillary Thyroid Carcinoma Based on Circular RNA-Associated Competing Endogenous RNA Mechanisms.
    Wu M; Li S; Han J; Liu R; Yuan H; Xu X; Li X; Liu Z
    Front Cell Dev Biol; 2020; 8():606327. PubMed ID: 33553144
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
    Wu M; Yuan H; Li X; Liao Q; Liu Z
    Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
    [No Abstract]   [Full Text] [Related]  

  • 3. Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma.
    Liu R; Cao Z; Wu M; Li X; Fan P; Liu Z
    BMC Med Genomics; 2023 Mar; 16(1):60. PubMed ID: 36973751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Regulatory Network and Role of the circRNA-miRNA-mRNA ceRNA Network in the Progression and the Immune Response of Wilms Tumor Based on RNA-Seq.
    Tian XM; Xiang B; Zhang ZX; Li YP; Shi QL; Li MJ; Li Q; Yu YH; Lu P; Liu F; Liu X; Lin T; He DW; Wei GH
    Front Genet; 2022; 13():849941. PubMed ID: 35559038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Circular RNA-Related Competing Endogenous RNA Identifies the Immune-Related Risk Signature for Colorectal Cancer.
    Song W; Ren J; Wang C; Ge Y; Fu T
    Front Genet; 2020; 11():505. PubMed ID: 32582276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five genes involved in circular RNA-associated competitive endogenous RNA network correlates with metastasis in papillary thyroid carcinoma.
    Qiu J; Sun M; Zang C; Jiang L; Qin Z; Sun Y; Liu M; Zhang W
    Math Biosci Eng; 2021 Oct; 18(6):9016-9032. PubMed ID: 34814333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA-related CeRNA network and prognostic signature for patients with oral squamous cell carcinoma.
    He Y; Yang D; Li Y; Xiang J; Wang L; Wang Y
    Front Pharmacol; 2022; 13():949713. PubMed ID: 36532732
    [No Abstract]   [Full Text] [Related]  

  • 8. Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer.
    Wang B; Shen W; Yan L; Li X; Zhang L; Zhao S; Jin X
    Ann Med; 2023; 55(2):2244515. PubMed ID: 37603701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
    Dong Q; Han Z; Tian L
    Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
    Chen F; Li Z; Deng C; Yan H
    J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Network-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer.
    Liu Q; Pan LZ; Hu M; Ma JY
    Pathol Oncol Res; 2020 Apr; 26(2):1293-1299. PubMed ID: 31289996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma.
    Li S; Ran MY; Qiao H
    Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of the functions and clinical implications of exosome circRNAs in colorectal cancer.
    Lei T; Zhang Y; Wang X; Liu W; Feng W; Song W
    Front Immunol; 2022; 13():919014. PubMed ID: 35924235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing.
    Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M
    Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes.
    Liu R; Cao Z; Pan M; Wu M; Li X; Yuan H; Liu Z
    Cancer Med; 2022 Dec; 11(23):4703-4720. PubMed ID: 35608185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer.
    Song W; Fu T
    Front Oncol; 2019; 9():1181. PubMed ID: 31781492
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma.
    Wang K; Xu J; Zhao L; Liu S; Liu C; Zhang L
    Front Genet; 2020; 11():805. PubMed ID: 32849806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer.
    Li H; Liu F; Wang X; Li M; Li Z; Xie Y; Guo Y
    Front Pharmacol; 2021; 12():748867. PubMed ID: 34721037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.